التفاصيل البيبلوغرافية
العنوان: |
Factors associated with progression free survival treated with lenvatinib. |
المؤلفون: |
Kenji Yamaoka (11965273), Kenichiro Kodama (8876240), Tomokazu Kawaoka (128666), Masanari Kosaka (11965276), Yusuke Johira (11965279), Yuki Shirane (11965282), Ryoichi Miura (11965285), Shigeki Yano (11965288), Serami Murakami (11965291), Kei Amioka (11965294), Kensuke Naruto (11965297), Yuwa Ando (11965300), Yumi Kosaka (11965303), Shinsuke Uchikawa (11032037), Takuro Uchida (756174), Hatsue Fujino (4348360), Takashi Nakahara (1677235), Eisuke Murakami (756173), Wataru Okamoto (6496550), Masami Yamauchi (8876237), Daiki Miki (128628), Michio Imamura (128656), Shoichi Takahashi (128660), Akiko Nagao (2637289), Kazuaki Chayama (128675), Hiroshi Aikata (128663) |
سنة النشر: |
2022 |
المجموعة: |
Smithsonian Institution: Digital Repository |
مصطلحات موضوعية: |
Biotechnology, Evolutionary Biology, Cancer, Science Policy, Virology, Chemical Sciences not elsewhere classified, various clinical data, univariate analysis showed, multivariate analysis showed, h0r ], bioelectrical impedance analysis, 33 – 5, 32 – 7, 03 – 11, +eighty%22">xlink "> eighty, body composition assessment, 23 – 3, longer overall survival, advanced hepatocellular carcinoma, os ), progression, tbw ≤ 0, %22">xlink ">, hepatocellular carcinoma, body composition, progression survival, ≤ 0, advanced hcc, longer os |
Time: |
4 |
الوصف: |
Factors associated with progression free survival treated with lenvatinib. |
نوع الوثيقة: |
dataset |
اللغة: |
unknown |
Relation: |
https://figshare.com/articles/dataset/Factors_associated_with_progression_free_survival_treated_with_lenvatinib_/18645160 |
DOI: |
10.1371/journal.pone.0262675.t003 |
الاتاحة: |
https://doi.org/10.1371/journal.pone.0262675.t003 |
Rights: |
CC BY 4.0 |
رقم الانضمام: |
edsbas.DC60B47F |
قاعدة البيانات: |
BASE |